CytoMed Therapeutics
(NASDAQ) GDTC
CytoMed Therapeutics Financials at a Glance
Market Cap
$12.66M
Revenue (TTM)
SGD 509.13K
Net Income (TTM)
-SGD 5.45M
EPS (TTM)
-$0.26
P/E Ratio
-4.10
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.03
Volume
0
Open
$1.13
Price
$1.03
Volume
0
Open
$1.13
Previous Close
$1.03
Daily Range
$1.03 - $1.13
52-Week Range
$0.68 - $3.68
Estimated Earnings Date
Nov 13, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.03
Volume
0
Open
$1.13
Previous Close
$1.03
Daily Range
$1.03 - $1.13
52-Week Range
$0.68 - $3.68
Estimated Earnings Date
Nov 13, 2026
GDTC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CytoMed Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
42
CEO
Wee Kiat Tan, PhD
Website
www.cytomed.sgHeadquarters
Singapore, 149544, SG
GDTC Financials
Key Financial Metrics (TTM)
Gross Margin
-35%
Operating Margin
-10%
Net Income Margin
-11%
Return on Equity
-52%
Return on Capital
-73%
Return on Assets
-68%
Earnings Yield
-24.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.66M
Shares Outstanding
11.83M
Volume
0
Avg. Volume
17.45K
Financials (TTM)
Gross Profit
-SGD 886.56K
Operating Income
-SGD 4.52M
EBITDA
-SGD 4.30M
Operating Cash Flow
-SGD 3.70M
Capital Expenditure
-SGD 703.13K
Free Cash Flow
-SGD 4.40M
Cash & ST Invst.
SGD 2.10M
Total Debt
SGD 482.56K
CytoMed Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
SGD 167.95K
+18.5%
Gross Profit
-SGD 555.65K
-537.3%
Gross Margin
-3.31%
N/A
Market Cap
$12.66M
N/A
Market Cap/Employee
$294.44K
N/A
Employees
43
N/A
Net Income
-SGD 1.73M
-138.8%
EBITDA
-SGD 2.22M
-232.6%
Quarterly Fundamentals
Total Cash
SGD 2.10M
-58.5%
Total Debt
SGD 482.56K
+2.6%
Accounts Receivable
SGD 132.05K
+592.7%
Inventory
SGD 0.00
-100.0%
Long Term Debt
SGD 422.12K
-0.4%
Short Term Debt
SGD 60.45K
+29.7%
Return on Assets
-68.28%
N/A
Return on Invested Capital
-73.39%
N/A
Free Cash Flow
-SGD 2.35M
-126.2%
Operating Cash Flow
-SGD 2.05M
-159.8%